- Pharmaceutical industry delivers value proposition to Finnish . . .
In 2023, pharmaceutical companies invested more than EUR 460 million in Finland, half of which went into R D and the other half into production On Friday 21 March, representatives of the pharmaceutical industry submitted the sector’s value proposition to Riikka Purra, the Minister of Finance
- Pharmaceutical industry offers €1 billion investment plan to Finnish . . .
Finland's pharmaceutical industry has proposed increasing investment to €1 billion by 2030, urging government support to improve the operating environment and expand clinical research
- Orion Oyj | Globenewswire - via. ritzau. dk
Pharmaceutical industry delivers value proposition to Finnish Government: billions to be invested by 2030 In 2023, pharmaceutical companies invested more than EUR 460 million in Finland, half of which went into R D and the other half into production
- Pharmaceutical industry delivers value proposition to - GlobeNewswire
In 2023, pharmaceutical companies invested more than EUR 460 million in Finland, half of which went into R D and the other half into production On Friday 21 March, representatives of the
- Pharmaceutical industry delivers value proposition to Finnish . . .
In 2023, pharmaceutical companies invested more than EUR 460 million in Finland, half of which went into R D and the other half into production On Friday 21 March, representatives of the
- Finlands Orion sending critical drugs to Russia, but future there . . .
MOSCOW, Oct 20 (Reuters) - Finnish drugmaker Orion said on Thursday it was still delivering certain critical medicines to Russia, but its future in the country was uncertain, as Russian media
- Orion Pharma - Building well-being
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients
- Orions blockbuster drug enables growth and renewal
To ensure that similar successful drugs can continue to be developed in Finland by a larger group, Orion is leading a flagship project funded by Business Finland to create an ecosystem focused on pharmaceutical development
|